News

Lyfegen and EVERSANA Collaborate to Revolutionize Drug Pricing and Access with AI-Driven Insights

BASEL, Switzerland, Jan. 28, 2025 /PRNewswire/ -- Lyfegen, a global innovator in drug market access, pricing, and rebate management, has announced…

11 months ago

Braviant Supports Mental Health Awareness with a Donation to UnLockeTheLight Foundation

CHICAGO, Jan. 28, 2025 /PRNewswire/ -- Braviant is proud to announce a contribution to the UnLockeTheLight Foundation during the 7th…

11 months ago

Recognizing the Highest Level of Quality Care: Healthgrades Unveils America’s Best Hospitals for 2025

Healthgrades recognizes the top 5% of U.S. hospitals for overall clinical care. DENVER, Jan. 28, 2025 /PRNewswire/ -- Healthgrades, the #1…

11 months ago

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader

Advances radiopharmaceutical leadership with addition of scalable manufacturing infrastructure and end-to-end clinical development capabilities Adds OCTEVY™, a registrational-stage diagnostic asset,…

11 months ago

UL Solutions and Eyesafe Collaborate to Advance Blue Light Protection

Guided by the latest health research and insights from doctors, Eyesafe is introducing new industry requirements for displays and screen…

11 months ago

Corsair Pharma Partners with InstantGMP® to Ensure Quality for Clinical Trials

CARY, N.C., Jan. 28, 2025 /PRNewswire/ -- InstantGMP™, a leader in fully integrated GMP-compliant software solutions for pharmaceutical manufacturing, proudly…

11 months ago

Inovalon Announces CEO Transition

Keith Dunleavy, M.D., Founder and CEO to retire, transition to Board of Directors Adam Kansler appointed as CEO for next…

11 months ago

Inovalon Announces CEO Transition

Keith Dunleavy, M.D., Founder and CEO to retire, transition to Board of Directors Adam Kansler appointed as CEO for next…

11 months ago

Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results

Company to Host Conference Call on Tuesday, February 25, 2025 at 8:30 am ETLEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a…

11 months ago

Persephone Biosciences Announces Full Enrollment in AMBROSIA Food as Medicine Study

- 400 participants with a medium-to-high risk of developing colorectal cancer (CRC) have been enrolled across two arms - -…

11 months ago